Emergency Contraception in DenmarkEuromonitor InternationalMarch 13, 2012 29 Pages - SKU: EP3818098 |
|
Emergency Contraception in Azerbaijan
4/10/2013 | published by: Euromonitor International
Emergency Contraception in Azerbaijan Still, there is no emergency contraception available in Azerbaijan. All medicines are Rx only Euromonitor International's Emergency Contraception in Azerbaijan report offers a comprehensive guide to the size and shape of the market
|
read more...
|
$900.00
|
|
Emergency Contraception in Kazakhstan
4/19/2013 | published by: Euromonitor International
Emergency Contraception in Kazakhstan Emergency contraception products in Kazakhstan are Rx, since they might be overused, particularly by younger consumers. Euromonitor International's Emergency Contraception in Kazakhstan report offers a comprehensive guide to the size and shape of
|
read more...
|
$900.00
|
|
Family Planning & Abortion Clinics in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Family Planning & Abortion Clinics in the US industry. Industry Risk is assumed to be 'the difficulty, or
|
read more...
|
$1,020.00
|
|
Emergency Contraception in Sweden
4/18/2013 | published by: Euromonitor International
Emergency Contraception in Sweden Increased price competition contributed to a slowdown in value growth for Swedish emergency contraception in 2012. This is primarily due to new importers that entered the market and increased competition. Euromonitor International's Emergency
|
read more...
|
$900.00
|
|
Emergency Contraception in Uruguay
3/25/2013 | published by: Euromonitor International
Emergency Contraception in Uruguay - Its approval delayed several times, the law of Voluntary Interruption of Pregnancy was approved by the Uruguayan Legislative Power and with the necessary regulatory decrees, which began to be applied
|
read more...
|
$900.00
|
|
Emergency Contraception in China
4/4/2013 | published by: Euromonitor International
The sales value of emergency contraception continued to grow in 2012, by 7%, as more women turned to these products to avoid unwanted pregnancies. The one-child policy in China, which restricts urban couples to having
|
read more...
|
$900.00
|
|
Contraceptives – Pipeline Review, H1 2013
2/28/2013 | published by: Global Markets Direct
Contraceptives – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Contraceptives - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Contraceptives, complete with latest
|
read more...
|
$2,000.00
|
|
Emergency Contraception in Australia
3/7/2013 | published by: Euromonitor International
Emergency contraception is available in Australia. The product is Schedule 3, which means it can only be sold from behind the counter, involving interaction with a pharmacist. The emergency contraceptive pill has been available in
|
read more...
|
$900.00
|
|
Contraception Manufacturers (Global) - Industry Report
3/18/2013 | published by: Plimsoll Publishing Ltd.
Plimsoll Publishing’s Contraception Manufacturers (Global) Analysis provides a detailed overview of the Contraception Manufacturers (Global) market and delivers a comprehensive individual analysis on the top 50 companies, including JOHNSON & JOHNSON, PAUL HARTMANN AG and
|
read more...
|
$1,425.00
|
|
The World Market for Rubber Sheath Contraceptives (Condoms): A 2013 Global Trade Perspective
1/1/2013 | published by: Icon Group International, Inc.
This report was created for strategic planners, international executives and import/export managers who are concerned with the market for rubber sheath contraceptives (condoms). With the globalization of this market, managers can no longer be contented
|
read more...
|
$595.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Reproductive Health Reports